Worth Venture Partners’s Gossamer Bio GOSS Stock Holding History

Worth Venture Partners’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-312,724	Closed	-$4.06M	–	2
2026 Q2	$4.12M	Buy	+312,724	New	+$6.98M	9.29%	3

Other funds holding GOSS

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

MB Generational Wealth Spokane, Washington $196M AUM 14.53% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return

Worth Venture Partners's GOSS Position: Q3 2026 in Review

Worth Venture Partners sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 312,724 shares — an estimated $4.06M sold.

Worth Venture Partners first reported a position in GOSS in Q2 2026 and held it in 1 quarter. The position peaked at $4.12M in Q2 2026. 37 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

Worth Venture Partners reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
Worth Venture Partners sold 312,724 Gossamer Bio shares in Q3 2026, an estimated $4.06M.
Worth Venture Partners first reported a position in Gossamer Bio in Q2 2026 and held it in 1 quarter.
Worth Venture Partners's Gossamer Bio position peaked at $4.12M in Q2 2026.
37 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Worth Venture Partners's 13F filing for Q3 2026, filed 12 Nov 2026.